glp-1 dpp 4 receptor agonists or DPP-4 inhibitors: How to guide the clinician? Infographic: Incretins and More: The

At Noor Medical Spa, we provide a comprehensive approach to Semaglutide GLP-1 treatment , ensuring safety, efficacy, and personalized care for weight management

Emerging opportunities for the treatment of metabolic diseases: GLP-1-based multi-agonists

Recent studies show that mental and emotional stress, along with nutrient deficiencies, influence eating disorders like binge eating, bulimia, and anorexia

Greater tolerability Tolerability is another factor to consider, given the intended long-term use of GLP-1s

However, there is a percentage, as much as 20% of people taking GLP-1s, who may not respond to the drug